Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components
Publication
, Conference
Schreiber, CA; Sakuma, T; Izumiya, Y; Bressin, RK; Basu, U; Koide, K; Asokan, A; Ikeda, Y
Published in: HUMAN GENE THERAPY
October 1, 2015
Duke Scholars
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
October 1, 2015
Volume
26
Issue
10
Start / End Page
A3 / A4
Location
Helsinki, FINLAND
Publisher
MARY ANN LIEBERT, INC
Conference Name
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schreiber, C. A., Sakuma, T., Izumiya, Y., Bressin, R. K., Basu, U., Koide, K., … Ikeda, Y. (2015). Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components. In HUMAN GENE THERAPY (Vol. 26, pp. A3–A4). Helsinki, FINLAND: MARY ANN LIEBERT, INC.
Schreiber, C. A., T. Sakuma, Y. Izumiya, R. K. Bressin, U. Basu, K. Koide, A. Asokan, and Y. Ikeda. “Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components.” In HUMAN GENE THERAPY, 26:A3–4. MARY ANN LIEBERT, INC, 2015.
Schreiber CA, Sakuma T, Izumiya Y, Bressin RK, Basu U, Koide K, et al. Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components. In: HUMAN GENE THERAPY. MARY ANN LIEBERT, INC; 2015. p. A3–4.
Schreiber, C. A., et al. “Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components.” HUMAN GENE THERAPY, vol. 26, no. 10, MARY ANN LIEBERT, INC, 2015, pp. A3–4.
Schreiber CA, Sakuma T, Izumiya Y, Bressin RK, Basu U, Koide K, Asokan A, Ikeda Y. Enhanced AAV vector transduction through genetic and pharmacological inhibition of U2 snRNP components. HUMAN GENE THERAPY. MARY ANN LIEBERT, INC; 2015. p. A3–A4.
Published In
HUMAN GENE THERAPY
EISSN
1557-7422
ISSN
1043-0342
Publication Date
October 1, 2015
Volume
26
Issue
10
Start / End Page
A3 / A4
Location
Helsinki, FINLAND
Publisher
MARY ANN LIEBERT, INC
Conference Name
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology